Author:
Brøsen Kim,Skjelbo Erik,Rasmussen Birgitte B.,Poulsen Henrik E.,Loft Steffen
Subject
Pharmacology,Biochemistry
Reference24 articles.
1. Fluvoxamine—a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness;Benfield;Drugs,1986
2. The P450 superfamily: update on new sequences, gene mapping, and recommended nomenclature;Nebert;DNA Cell Biol,1991
3. Inhibitors of imipramine metabolism by human liver microsomes;Skjelbo;Br J Clin Pharmacol,1992
4. The mephenytoin oxidation polymorphism is partially responsible for the N-demethylation of imipramine;Skjelbo;Clin Pharmacol Ther,1991
5. Lemoine A, Gautier JC, Azoulay D, Kiffel L, Guengerich FP, Beaune P, Maurel P and Leroux JP, The major pathway of imipramine metabolism is catalysed by cytochromes P-450 1A2 and P-450 3A4 in human liver, submitted.
Cited by
347 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献